Prospective Grant of an Exclusive Patent License: Development and Commercialization of BL-760 Dye for Intraoperative Fluorescence Imaging
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents and patent applications listed in the Supplementary Information section of this notice to OptoSurgical LLC ("OptoSurgical"), a company located in Columbia, Maryland, the United States of America.
Related coverage
- Presidential Declaration of a Major Disaster for Public Assistance Only for the State of West Virginia
- Presidential Declaration of a Major Disaster for Public Assistance Only for the State of Hawaii
- Removing Deference to Prior USCIS Determinations of Eligibility
- Removal of Automatic Extensions for Certain Employment Authorization Documents
- Removing 30-Day Refugee Termination Notice
- Trichloroethylene (TCE); Regulation Under the Toxic Substances Control Act (TSCA); Compliance Date Extensions